BioSpace News Archive

The latest market analysis report published by Reports and Data, titled ‘Global Taxifolin Market – Forecast to 2028,’ thoroughly examines the Taxifolin industry to provide essential data & information for the targeted readers. The report consists of quantitative and qualitative research on the market performed by our market experts.

The latest market analysis report published by Reports and Data, titled ‘Global Spinal Cord Stimulation Devices Market – Forecast to 2028,’ thoroughly examines the Spinal Cord Stimulation Devices industry to provide essential data & information for the targeted readers.

G42 Healthcare, an Abu Dhabi-based leading health tech company and subsidiary of G42, an artificial intelligence and cloud computing company located in Abu Dhabi has signed a letter of intent (LOI) with global biopharmaceutical company, AstraZeneca.

The Study provides in-depth comprehensive analysis for regional segments that covers North America, Europe, Asia-Pacific, Middle East and Africa with global outlook and includes Clear Market definitions, classifications, manufacturing processes, cost structures, development policies and plans.

Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its latest TGaS report entitled, Reimagining Work Models in the Life Sciences: Implications for the Future of Work.

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced it has received approval by the Bellberry Human Research Ethics Committee (HREC) in Australia to initiate the next phase of its BioLexa trial for patients suffering with Atopic Dermatitis.

According to Nova one advisor, the U.S. Home Healthcare market size was valued at US$ 132.9 billion in 2021 and is expected to hit US$ 253.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.50% from 2022 to 2030.

The U.S. Psychiatry Clinic market size was valued at US$ 23.7 billion in 2021 and is expected to hit US$ 34.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.7% from 2022 to 2030.

According Vision Research Reports, the global Healthcare Additive Manufacturing market size is expected to hit around US$ 11.5 billion by 2030 from valued at US$ 1.5 Billion in 2021 and is anticipated to grow at a CAGR of 22.5% during forecast period 2022 to 2030.

According to Report, the global next-generation sequencing market size is projected to be worth around US$ 38.5 billion by 2030 and is expected to grow at a CAGR of 14.6% from 2022 to 2030.